# Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients

> **NCT02874391** · — · UNKNOWN · sponsor: **University Hospital, Angers** · enrollment: 50 (estimated)

## Conditions studied

- Evaluate the Risks of Using Arteriovenous Fistula as First Choise for Drug Administration

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02874391
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02874391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02874391, "Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02874391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*